4.5 Article

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

Yunda Huang et al.

Summary: The study examines the pharmacokinetics and neutralization coverage of VRC01 antibody in different cohorts to determine its effectiveness in preventing HIV-1 infection. Results suggest that differences in body weight and gender may impact the pharmacokinetics of VRC01. The study provides insights into interpreting the AMP trial results and investigating the correlation between VRC01 concentration, neutralization, and HIV incidence.

EBIOMEDICINE (2021)

Article Virology

Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses

Stella J. Berendam et al.

Summary: Optimal bNAb immunotherapeutics will need to mediate multiple antiviral functions against a broad range of HIV strains. Our systematic assessment of triple bNAb combinations against SHIVs will identify bNAbs with synergistic, polyfunctional antiviral activity that will inform the selection of candidate bNAbs for optimal combination designs. The identified combinations can be validated in vivo in future passive immunization studies using the SHIV challenge model.

JOURNAL OF VIROLOGY (2021)

Review Medicine, Research & Experimental

Broadly Neutralizing Antibodies for HIV Prevention

Shelly T. Karuna et al.

ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)

Article Immunology

Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01

Yunda Huang et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)

Review Biochemical Research Methods

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

Marcella Sarzotti-Kelsoe et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

Article Medicine, Research & Experimental

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones

Riccardo Miglietta et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)

Article Computer Science, Interdisciplinary Applications

Estimation of the concordance correlation coefficient for repeated measures using SAS and R

Josep L. Carrasco et al.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2013)

Article Multidisciplinary Sciences

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

Tongqing Zhou et al.

SCIENCE (2010)

Article Pharmacology & Pharmacy

The Concordance Correlation Coefficient for Repeated Measures Estimated by Variance Components

Josep L. Carrasco et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)

Article Biochemistry & Molecular Biology

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

Lin Shen et al.

NATURE MEDICINE (2008)

Article Pharmacology & Pharmacy

Ways to fit a PK model with some data below the quantification limit

SL Beal

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)